Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection
Authors
Discussion
Loading...
Member takes
Implication
Review reveals limited predictive accuracy of immune-based tuberculosis assays in at-risk populations, suggesting screening be targeted via multivariable risk models.
Key Points
- To evaluate the diagnostic utility, comparative performance, and clinical limitations of gamma interferon release assays and tuberculin skin tests for detecting latent tuberculosis infection.
- Synthesized clinical evidence assessing the diagnostic performance of the tuberculin skin test (TST) and gamma interferon release assay (IGRA) as indirect immune markers of Mycobacterium tuberculosis exposure.
- Evaluated test accuracy across disease stages, sensitivity in immunocompromised populations, and strategies for predictive risk stratification.
- Both TST and IGRA detect cellular immune responses to Mycobacterium tuberculosis exposure but fail to distinguish latent infection from active disease, differentiate reactivation from reinfection, or identify intermediate infection stages.
- Both diagnostic tests display reduced sensitivity in immunocompromised patients and exhibit low positive predictive value for progression to active tuberculosis.
- Targeting screening to high-risk individuals through multivariable clinical risk prediction models and serial testing optimizes diagnostic utility while novel biomarkers are developed.
Cite This Study
Pai et al. (2014) studied this question.